AHFS May 2023 Update

This update contains 4 new monographs and 25 revised monographs.

New monographs: Omaveloxolone; Pegcetacoplan (EENT); Sparsentan; Velmanase Alfa-tycv.

Revised monographs: Ambrisentan; Apixaban; Belimumab; Bosentan; Dabigatran; Dupilumab; Emicizumab-kxwh; Epoprostenol; Iloprost; Inebilizumab-cdon; Macitentan; Misoprostol; Naloxone; Nitric Oxide; Omidenepag Isopropyl; Pneumococcal Vaccine; Riociguat; Rivaroxaban; Selexipag; Sildenafil; Smallpox and Mpox Vaccine Live; Tadalafil; Tecovirimat; Treprostinil; Warfarin.